Sociedad Americana de Hirudoterapia

[The medicinal leech Hirudo medicinalis: clinical use of the animal and therapeutic prospects of hirudin]

Research article published in Journal de pharmacie de Belgique (1990)

Última actualización: March 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Ensayos clínicosDesarrollo de fármacosGenómica y proteómicaHenriot J et al. · Journal de pharmacie de Belgique, 1990

Abstract

Blood sucking leech, Hirudo medicinalis, used in Medicine for very long, knew an intensive employment during early 18e century but its excess was responsible of the temporary disparition of the animal from the therapeutics. Leech has currently recovered a clinical use, especially in microsurgery. On the other hand, hirudin, main active compound isolated from leech extract and also known and used for long, offers interesting outlooks by its anticoagulant and antithrombic properties. This explains the great interest of hirudin preparation by molecular genetics.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEnglish AbstractJournal ArticleReview
Indexed MeSH termsAnimalsGenetic EngineeringHirudin TherapyHirudinsHumansLeechesRecombinant Proteins

Resumen

Blood sucking leech, Hirudo medicinalis, used in Medicine for very long, knew an intensive employment during early 18e century but its excess was responsible of the temporary disparition of the animal from the therapeutics.

Por qué esto importa para la hirudoterapia

Contributes clinical evidence for the therapeutic application of leech therapy.

Citación

[The medicinal leech Hirudo medicinalis: clinical use of the animal and therapeutic prospects of hirudin].

Henriot J et al. · Journal de pharmacie de Belgique, 1990

Contexto clínico relacionado

Añadido a la biblioteca ASH: March 18, 2026 · Última actualización del sitio: March 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.

[The medicinal leech Hirudo medicinalis: clinical use of the animal and therapeutic prospects of hirudin] | ASH